To evaluate if Rb1 treatment improved central leptin sensitivity in conjunction with the inhibition of hypothalamic inflammation, central leptin sensitivity was examined at two stages in the development of obesity, at 8 and 16 weeks of HF diet. The gene discussed is RB1; the disease is hydrops fetalis.